Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
While endocrinologists and internists still dominate prescribing, nondiabetes specialists have increased GLP1 prescribing by 900% since 2020, signaling a fundamental shift in perception and adoption as audiences expand beyond traditional prescribers
Evening routine 13
Month 2 Summary: You Survived Weight loss: 4-7 pounds this month (8-11 pounds total, 4-5% of starting weight) Peak nausea: Weeks 6-7 rated moderate to severe by 65% of people Side effects: Highest throughout entire 48-week treatment Discontinuation rate: 15-18% stop during month 2 (highest attrition period) Psychological state: Tested resolve, questioned decisions, but persisted Key achievement: Proved you can handle difficult periods
The online/direct-to-consumer (DTC) segment is expected to grow at the fastest CAGR in the coming years due to the increasing preference for home delivery and digital access to medications, which offers convenience and privacy for patients managing chronic obesity
